Why the pattern matters more than any single value, and how focused testing clarifies the diagnosis, kidney and bone risk, and follow-up.
Primary hyperparathyroidism (PHPT) begins in the parathyroid glands, usually when one gland becomes overactive and releases too much parathyroid hormone (PTH). Because PTH regulates calcium through the bones, kidneys, and vitamin D pathways, the condition cannot be understood from a calcium result or a PTH result alone.
The most useful approach is to connect five parts of the same story: calcium, PTH, vitamin D status, kidney results, and bone findings. That combined pattern can reveal parathyroid-driven hypercalcemia before a kidney stone, fragility fracture, or meaningful loss of kidney function becomes obvious. Ulta Lab Tests provides direct online access to many relevant blood and urine tests where available, but laboratory results are informational. They do not replace a clinician's diagnosis, physical examination, bone-density testing, imaging, or treatment plan.
Answer in brief: Primary hyperparathyroidism is an endocrine disorder in which one or more parathyroid glands release more PTH than the calcium level should require. The usual biochemical pattern is persistently high calcium with PTH that is elevated or not appropriately suppressed.
PTH is the body's calcium-regulating signal. When calcium falls, healthy parathyroid glands release PTH, which helps raise blood calcium by changing calcium movement from bone, kidney calcium handling, and vitamin D-mediated absorption from the intestine. When calcium rises, PTH should fall.
In PHPT, that feedback loop no longer works normally. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) reports that about 8 in 10 cases involve a single benign parathyroid adenoma. Other cases may involve more than one adenoma or multigland hyperplasia; parathyroid cancer is rare.[1]
Many people have no distinctive symptoms. Fatigue, constipation, low mood, poor concentration, muscle weakness, thirst, and frequent urination can occur, but each has many possible causes. That is why objective results - especially the relationship between calcium and PTH over time - matter more than symptoms alone.
Answer in brief: Excess PTH can affect bone strength and kidney health even when a person feels well. Laboratory testing identifies the biochemical pattern, while DXA and imaging show whether target organs have already been affected.
Persistent PTH activity can increase the movement of calcium out of bone. Over time, this may contribute to osteopenia, osteoporosis, or fragility fracture. The distal one-third radius in the forearm is particularly important because PHPT can preferentially affect cortical bone. A routine DXA that evaluates only the spine and hip can miss this site.
Higher blood calcium can increase the calcium filtered through the kidneys. Some people develop hypercalciuria, kidney stones, calcium deposits within the kidney (nephrocalcinosis), or declining filtration. Stones may be silent, so a history without classic flank pain does not fully exclude kidney involvement.
More pronounced hypercalcemia may cause poor appetite, nausea, vomiting, constipation, excessive thirst, frequent urination, dehydration, confusion, or marked muscle weakness. These findings are not specific to PHPT, but they become more concerning when paired with a clearly elevated calcium result.
| Finding or situation | What it may suggest | Related tests that may add information |
|---|---|---|
| Repeated high calcium on routine testing | Persistent hypercalcemia that needs confirmation and PTH interpretation | Comprehensive Metabolic Panel Test - CMP, Calcium Test, Albumin Test, and PTH Intact Test collected together |
| Kidney stones, flank pain, or blood in urine | Increased urinary calcium or another stone-risk disorder | Renal Function Panel Test, Urinalysis Complete Test, and Calcium 24-Hour Urine Test with Creatinine, plus kidney imaging when indicated |
| Osteopenia, osteoporosis, height loss, or low-trauma fracture | Possible skeletal effects of excess PTH or another bone disorder | Calcium Test, PTH Intact Test, Vitamin D 25-Hydroxy Total Test, and Alkaline Phosphatase Test, plus three-site DXA and vertebral assessment |
| Fatigue, weakness, constipation, thirst, or frequent urination | Possible hypercalcemia, dehydration, or an unrelated condition | Comprehensive Metabolic Panel Test - CMP, PTH Intact Test, Phosphate (as Phosphorus) Test, and Magnesium Test |
| High PTH with normal total calcium | Secondary hyperparathyroidism is common; normocalcemic PHPT requires exclusion | Repeat Calcium Test, Calcium Ionized Test, Vitamin D 25-Hydroxy Total Test, and Renal Function Panel Test |
| Lifelong mild hypercalcemia, young age, low urine calcium, or family history | Possible FHH or another inherited calcium disorder | Calcium 24-Hour Urine Test with Creatinine, concurrent serum calcium and creatinine, and possible clinician-directed genetic evaluation |
Safety note: Seek prompt medical care for new confusion, fainting, repeated vomiting, inability to stay hydrated, rapidly worsening weakness, very low urine output, severe abdominal or flank pain, or significant palpitations. Society for Endocrinology emergency guidance considers calcium above 3.5 mmol/L (about 14 mg/dL) to require urgent correction because of the risk of dysrhythmia and coma; severe symptoms can require urgent care at lower levels.[5]
Lab testing can confirm that calcium is persistently elevated, show whether the PTH response is appropriate, uncover vitamin D deficiency or kidney dysfunction, and quantify urinary calcium. Trends are often more informative than one result because hydration, albumin, supplements, medications, recent illness, and laboratory variation can shift individual values.
Lab tests cannot measure bone density, show every kidney stone, or locate an abnormal parathyroid gland. DXA and kidney imaging address different questions. Neck ultrasound, sestamibi scanning, and four-dimensional CT are localization studies used for surgical planning after a biochemical diagnosis has been established; they are not screening tests for PHPT.[2]
| Laboratory pattern | General interpretation | Important next considerations |
|---|---|---|
| High calcium with high or inappropriately normal PTH | Parathyroid-dependent hypercalcemia; the classic PHPT pattern | Confirm on two occasions, review albumin and medications, then assess vitamin D, kidney function, urine calcium, bones, and kidneys |
| High calcium with suppressed PTH | Points away from PHPT | Clinician-directed evaluation for non-parathyroid causes, such as malignancy-associated hypercalcemia, excess vitamin D activity, granulomatous disease, hyperthyroidism, immobilization, or medication effects |
| Normal total and ionized calcium with high PTH | Secondary hyperparathyroidism is more common; normocalcemic PHPT is a diagnosis of exclusion | Exclude vitamin D deficiency, chronic kidney disease, low calcium intake, malabsorption, bariatric surgery, hypercalciuria, and medication effects; repeat over 3 to 6 months |
| Low calcium with high PTH | An appropriate secondary PTH response is more likely | Evaluate vitamin D, magnesium, kidney function, intake, and absorption based on the clinical picture |
| High calcium with nonsuppressed PTH and unusually low urine calcium | May suggest FHH | Review collection quality, family history, vitamin D, kidney function, thiazides, and lithium; use a clearance ratio and genetic evaluation when appropriate |
The Fifth International Workshop defines hypercalcemic PHPT as elevated albumin-adjusted calcium with elevated or inappropriately normal intact PTH on two occasions at least two weeks apart. It defines normocalcemic PHPT as normal adjusted total and ionized calcium with elevated PTH on at least two occasions over 3 to 6 months, after reasonable secondary causes have been excluded.[2]
| Test or panel | What it measures and why it matters | General pattern | Important limits |
|---|---|---|---|
| Comprehensive Metabolic Panel Test - CMP, Calcium Test, and Albumin Test | Total calcium is often the first clue. Albumin provides context because much circulating calcium is protein-bound. A CMP also supplies creatinine and other metabolic markers. | Persistent high calcium supports true hypercalcemia when confirmed. | Dehydration, albumin changes, medications, and non-parathyroid conditions can raise total calcium. Albumin-adjustment formulas are estimates. |
| PTH Intact Test | Measures intact PTH and shows whether the parathyroid response fits the calcium level. | High or nonsuppressed PTH with high calcium supports a parathyroid-driven pattern. | Must be collected and interpreted with calcium. Kidney dysfunction and vitamin D deficiency can raise PTH; biotin can interfere with some assays. |
| Calcium Ionized Test or PTH Intact Test with Ionized Calcium | Measures the unbound, biologically active calcium fraction and can clarify discordant results. | High ionized calcium supports true hypercalcemia; normal ionized calcium is required for a normocalcemic PHPT pattern. | Specimen handling and pH matter. It is not necessary in every straightforward case. Avoid duplicating separately ordered components. |
| Vitamin D 25-Hydroxy Total Test | Assesses vitamin D stores and a common secondary driver of elevated PTH. | Low 25-hydroxyvitamin D can raise PTH and complicate interpretation. | Does not diagnose PHPT. Supplement changes should be individualized, particularly when calcium or urine calcium is high. |
| Phosphate (as Phosphorus) Test | Reflects PTH-mediated kidney phosphorus handling. | PHPT may produce low or low-normal phosphorus. | Supports the pattern but cannot establish or exclude PHPT by itself. Kidney function and nutrition also affect the result. |
| Magnesium Test | Adds mineral context because magnesium disturbances can affect PTH secretion and calcium balance. | Low or high magnesium may complicate calcium-PTH interpretation. | Serum magnesium is an imperfect measure of total-body stores and is not a stand-alone PHPT test. |
| Renal Function Panel Test, Creatinine Test, and eGFR | Assess filtration and identify kidney impairment that can cause secondary PTH elevation or represent PHPT target-organ involvement. | Reduced filtration changes PTH and mineral physiology; eGFR below 60 mL/min is a surgical guideline criterion in confirmed PHPT. | eGFR is an estimate. Current guidance prefers creatinine clearance for monitoring when available.[2] |
| Calcium 24-Hour Urine Test with Creatinine | Quantifies daily urine calcium and includes urine creatinine to help judge collection plausibility. | Hypercalciuria supports stone-risk assessment; unusually low urine calcium may raise the possibility of FHH. | Collection errors, kidney disease, vitamin D deficiency, low calcium intake, thiazides, and lithium can lower urine calcium. The clearance ratio also needs concurrent serum calcium and creatinine. |
| Alkaline Phosphatase Test | Provides broad liver and bone-turnover context. | It may rise with increased bone turnover or another liver/bone process. | It is nonspecific and can be normal in PHPT. DXA and imaging, not ALP, measure skeletal complications. |
| Celiac Disease Comprehensive Panel when clinically indicated | Evaluates celiac-related antibodies when symptoms or risk factors suggest malabsorption. | A celiac pattern may help explain vitamin D deficiency, low calcium absorption, and secondary PTH elevation. | Not part of routine PHPT testing. Testing should occur before starting a gluten-free diet and requires clinical interpretation. |
Not everyone needs every test. The most efficient approach starts with the biochemical question and adds tests only when the preceding results or history justify them.
Repeat an unexpected calcium elevation when clinically appropriate. Obtain calcium, albumin, and intact PTH from the same blood draw so the feedback relationship can be evaluated directly. A Comprehensive Metabolic Panel Test - CMP can supply calcium, albumin, creatinine, and other metabolic context; a PTH Intact Test adds the essential hormone result.
Add a Calcium Ionized Test when total calcium is discordant with albumin or the clinical picture, or when normocalcemic PHPT is being considered. A Vitamin D 25-Hydroxy Total Test, Renal Function Panel Test, Phosphate (as Phosphorus) Test, and Magnesium Test can help distinguish primary disease from secondary PTH elevation. Malabsorption testing should be symptom- and history-directed.
Once the biochemical pattern supports PHPT, a Calcium 24-Hour Urine Test with Creatinine can help quantify calcium excretion, assess hypercalciuria, and evaluate possible FHH. Guideline-based assessment also includes kidney imaging for stones or nephrocalcinosis and three-site DXA of the lumbar spine, hip, and distal one-third radius, with vertebral assessment when indicated.[2]
For clinician-supervised monitoring, the Fifth International Workshop recommends annual calcium and 25-hydroxyvitamin D, PTH when clinically indicated, and annual creatinine clearance (preferred) or eGFR. Three-site DXA is generally repeated every 1 to 2 years unless normal bone density supports a longer interval; kidney imaging and repeat urine calcium are used when clinically indicated.[2]
FHH is an inherited change in calcium sensing that often causes lifelong mild hypercalcemia with relatively low urinary calcium. It matters because parathyroid surgery generally does not correct the underlying calcium pattern.
A calcium-to-creatinine clearance ratio below 0.01 favors FHH, especially in a younger person or someone with a family history of hypercalcemia. The ranges overlap, however. The Fifth International Workshop notes that some people with PHPT have ratios below 0.01, some people with FHH have ratios above 0.02, and values from 0.01 to 0.02 are common in both conditions. Kidney dysfunction, vitamin D deficiency, low calcium intake, thiazides, lithium, and incomplete urine collection can also lower urinary calcium.[2]
The practical message is simple: low urine calcium is a clue, not a diagnosis. A qualified clinician may need to review concurrent serum results, collection quality, lifelong trends, family history, and genetic testing before management decisions are made.
Parathyroidectomy is the definitive treatment for confirmed PHPT, but the decision is individualized with an experienced clinician and surgeon. The Fifth International Workshop recommends surgery for symptomatic disease and advises a surgical discussion when any one of the following is present in otherwise asymptomatic hypercalcemic PHPT:[2]
These are professional decision criteria, not a self-treatment checklist. Surgery can still be considered outside these thresholds when the patient and clinician agree and there is no contraindication. Current guidance does not recommend surgery solely to improve nonspecific cognitive, quality-of-life, or cardiovascular findings because the evidence remains inconclusive.
Interpret calcium and PTH together. A PTH value flagged "normal" may be inappropriate when calcium is high because normal glands should suppress hormone release. Conversely, a high PTH result with normal calcium does not prove normocalcemic PHPT.
Reference ranges vary by assay, units, age, kidney function, and laboratory method. "Optimal" ranges promoted outside standard clinical guidance are not separate diagnostic standards. A mildly abnormal result does not automatically mean disease, and a normal result does not always close the question when the paired physiology is inconsistent.
Albumin, hydration, recent illness, pregnancy, supplements, and medications can alter interpretation. Thiazide diuretics and lithium affect calcium physiology. Calcium, vitamin D, calcium-containing antacids, bisphosphonates, and denosumab may change the broader pattern. Biotin can produce a falsely low PTH result with some assays; the international guideline notes that stopping biotin for at least 48 hours has been suggested, but the correct interval depends on dose, assay, and test instructions. Do not stop a prescribed medication or change supplements without professional guidance.
For established PHPT, the workshop recommends maintaining 25-hydroxyvitamin D above 30 ng/mL and below the laboratory upper limit, often about 50 ng/mL, through cautious clinician-guided supplementation. It also advises calcium intake consistent with general nutritional guidance rather than a self-directed low-calcium diet.[2]
Ulta Lab Tests allows consumers to order many relevant blood and urine tests online where available. Testing is performed through established laboratory networks such as Quest Diagnostics where applicable. Pricing is shown before ordering, insurance is not required, HSA or FSA payment may be available for eligible purchases, and results are delivered through a secure online account.
Direct access can make confirmation and trend review more convenient, but Ulta Lab Tests does not diagnose primary hyperparathyroidism, determine whether surgery is needed, or replace DXA, imaging, genetic counseling, or professional medical care.
Explore parathyroid hormone and calcium tests or review the focused options below:
The core results are total calcium, albumin, and intact PTH measured together. A Comprehensive Metabolic Panel Test - CMP adds creatinine and metabolic context. A Vitamin D 25-Hydroxy Total Test, phosphorus, and kidney markers help identify secondary causes. A Calcium Ionized Test may clarify discordant total calcium or possible normocalcemic disease.
Yes. When calcium is elevated, normal parathyroid glands should suppress PTH. A value within the laboratory reference range may therefore be "inappropriately normal" if it remains nonsuppressed. Clinicians interpret the PTH Intact Test in relation to calcium, albumin, kidney function, vitamin D, medications, and repeat results rather than relying only on the high or normal flag.
It more often reflects secondary hyperparathyroidism from vitamin D deficiency, chronic kidney disease, low calcium intake, malabsorption, bariatric surgery, hypercalciuria, or medication effects. Normocalcemic PHPT is considered only after adjusted total and ionized calcium remain normal, PTH remains elevated on repeat testing over 3 to 6 months, and reasonable secondary causes have been excluded.
The Fifth International Workshop defines hypercalcemic PHPT using elevated albumin-adjusted calcium plus elevated or inappropriately normal PTH on two occasions at least two weeks apart. This is a guideline definition, not permission to delay care. Markedly elevated calcium, pregnancy, rapidly changing results, or concerning symptoms can require faster clinician-directed evaluation.
A Calcium 24-Hour Urine Test with Creatinine measures daily calcium excretion, helps assess hypercalciuria and stone risk, and supplies urine creatinine to judge collection plausibility. It can also contribute to the distinction between PHPT and FHH. The calcium-to-creatinine clearance ratio requires concurrent serum calcium and creatinine and still overlaps between the two disorders.
Low vitamin D can stimulate PTH and produce a secondary pattern that resembles or intensifies parathyroid disease. Vitamin D status also matters for bone health and safe management. A Vitamin D 25-Hydroxy Total Test provides the relevant storage-form measurement. High-dose supplementation should not be started or changed solely to manipulate PTH without clinician oversight.
They provide part of the answer. Creatinine, eGFR, and urine calcium help assess filtration and calcium excretion, while mineral markers provide context. They do not show bone density, silent vertebral fractures, kidney stones, or nephrocalcinosis. Those questions require three-site DXA, vertebral assessment, and kidney imaging when clinically indicated.
No. PHPT is established from the biochemical calcium-PTH pattern after reasonable alternatives are considered. Neck ultrasound, sestamibi scanning, and four-dimensional CT help locate abnormal gland tissue after a decision for surgery has been made. A negative scan does not exclude PHPT, and an apparent abnormal gland does not establish the disease without appropriate laboratory results.
Many calcium and PTH tests do not require fasting, but the instructions vary by product and any tests ordered with them. Ulta Lab Tests offers many relevant tests for direct online ordering where available. Follow the exact collection instructions and review results with a qualified healthcare provider, especially when calcium is clearly elevated or several results conflict.
New confusion, fainting, repeated vomiting, inability to hydrate, severe or rapidly worsening weakness, very low urine output, significant palpitations, or a markedly high calcium result warrant prompt medical assessment. Hypercalcemia during pregnancy or alongside known cancer also needs clinician-directed evaluation. Routine direct-access retesting is not an appropriate substitute for urgent care when symptoms or values are severe.
Primary hyperparathyroidism testing works best when calcium, PTH, vitamin D, kidney function, urinary calcium, and bone findings are read as one connected pattern. That approach can distinguish a parathyroid-driven problem from secondary hyperparathyroidism, FHH, medication effects, and non-parathyroid hypercalcemia while identifying kidney or skeletal risk that symptoms may not reveal.
Explore parathyroid hormone and calcium tests through Ulta Lab Tests, follow the preparation instructions for the specific order, and review all abnormal or discordant results with a qualified healthcare provider. Lab testing supports informed decisions; it does not replace diagnosis, imaging, or treatment planning.
Primary hyperparathyroidism is an endocrine disorder in which one or more parathyroid glands release more PTH than the calcium level should require. The classic pattern is persistently high albumin-adjusted calcium with elevated or inappropriately normal intact PTH on repeat testing.
Related laboratory tests: Comprehensive Metabolic Panel Test - CMP, PTH Intact Test, Calcium Ionized Test, Vitamin D 25-Hydroxy Total Test, Phosphate (as Phosphorus) Test, Renal Function Panel Test, and Calcium 24-Hour Urine Test with Creatinine.
Ulta Lab Tests helps patients order many relevant blood and urine tests online where available, view transparent pricing, and receive results securely for informed healthcare-provider discussions.
Disclaimer: Lab testing is informational and should be interpreted with a qualified healthcare provider. It does not replace diagnosis, imaging, or treatment planning.
Bone-density testing, kidney imaging, and parathyroid imaging are discussed in the article but are not blood or urine laboratory tests.
Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)
